PDCD1 and neoplasm: Therefore, the therapeutic effect of the combination of miR-21–3p-AuNp and anti-PD-1 antibody was attributed to the CD8+ T cells-dependent antitumor immunity and IFN-γ-driven tumor cell ferroptosis.